Applied Protein Technology

  • APTBio closes near-RMB200m Series A round

    The biotech company APT Bio recently announced that it has completed Series A financing round, raising nearly 200 million yuan. The leading investor for this round is Luxin Venture Capital, with participation from Guangzhou-based Funway Capital and others.